A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa
The aim of this study was to compare the inhibitory effect of antibiotic combinations in vitro with efficacy in Galleria mellonella larvae in vivo to identify efficacious combinations that target Pseudomonas aeruginosa. P. aeruginosa NCTC 13437, a multidrug-resistant strain resistant to β-lactams and aminoglycosides, was used. Susceptibility to cefotaxime, piperacillin, meropenem, amikacin, levofloxacin and colistin alone, or in dual or triple combinations, was measured in vitro via a 24 h time-kill assay. In vitro results were then compared with the efficacy of the same dual or triple antibiotic combinations versus G. mellonella larvae infected with P. aeruginosa. G. mellonella haemolymph burden of P. aeruginosa was determined over 96 h post-infection and treatment with the most potent combination therapies. Many dual and triple combinations of antibiotics displayed synergistic inhibition of multidrug-resistant P. aeruginosa in vitro. There was little correlation between combinations that were synergistic in vitro and those that showed enhanced efficacy in vivo versus infected G. mellonella larvae. The most potent dual and triple combinations in vivo were cefotaxime plus piperacillin, and meropenem plus piperacillin and amikacin, respectively. Fewer combinations were found to offer enhanced therapeutic benefit in vivo compared with in vitro. The therapeutic benefit arising from treatment with antibiotic combinations in vivo correlated with reduced larval burden of P. aeruginosa. This study has identified antibiotic combinations that merit further investigation for their clinical potential and has demonstrated the utility of using G. mellonella to screen for novel antibiotic treatments that demonstrate efficacy in vivo.
Al-HasanM. N., WilsonJ. W., LahrB. D., ThomsenK. M., Eckel-PassowJ. E., VetterE. A., TleyjehI. M., BaddourL. M.2009; β-lactam and fluoroquinolone combination antibiotic therapy for bacteremia caused by Gram-negative bacilli. Antimicrob Agents Chemother 53:1386–1394 [View Article][PubMed]
ChandrasekarP. H., CraneL. R., BaileyE. J.1987; Comparison of the activity of antibiotic combinations in vitro with clinical outcome and resistance emergence in serious infection by Pseudomonas aeruginosa in non-neutropenic patients. J Antimicrob Chemother 19:321–329 [View Article][PubMed]
HeW., KanigaK., LynchA. S., FlammR. K., DaviesT. A.2012; In vitro Etest synergy of doripenem with amikacin, colistin, and levofloxacin against Pseudomonas aeruginosa with defined carbapenem resistance mechanisms as determined by the Etest method. Diagn Microbiol Infect Dis 74:417–419 [View Article][PubMed]
HilfM., YuV. L., SharpJ., ZuravleffJ. J., KorvickJ. A., MuderR. R.1989; Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 87:540–546 [View Article][PubMed]
HillL., VeliN., CooteP. J.2013; Evaluation of Galleria mellonella larvae for measuring the efficacy and pharmacokinetics of antibiotic therapies against Pseudomonas aeruginosa infection. Int J Antimicrob Agents 43:254–261 [View Article][PubMed]
ScribnerR. K., MarksM. I., WeberA. H., TarpayM. M., WelchD. F.1982; Activities of various β-lactams and aminoglycosides, alone and in combination, against isolates of Pseudomonas aeruginosa from patients with cystic fibrosis. Antimicrob Agents Chemother 21:939–943 [View Article][PubMed]
SpencerR. C.1996; Predominant pathogens found in the European prevalence of infection in intensive care study. Eur J Clin Microbiol Infect Dis 15:281–285 [View Article][PubMed]
TammaP. D., CosgroveS. E., MaragakisL. L.2012; Combination therapy for treatment of infections with Gram-negative bacteria. Clin Microbiol Rev 25:450–470 [View Article][PubMed]
VardakasK. Z., TansarliG. S., BliziotisI. A., FalagasM. E.2013; β-Lactam plus aminoglycoside or fluoroquinolone combination versus β-lactam monotherapy for Pseudomonas aeruginosa infections: a meta-analysis. Int J Antimicrob Agents 41:301–310 [View Article][PubMed]
WhiteR. L., BurgessD. S., ManduruM., BossoJ. A.1996; Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40:1914–1918[PubMed]
WinstonD. J., HoW. G., BrucknerD. A., ChamplinR. E.1991; Beta-lactam antibiotic therapy in febrile granulocytopenic patients. A randomized trial comparing cefoperazone plus piperacillin, ceftazidime plus piperacillin, and imipenem alone. Ann Intern Med 115:849–859 [View Article][PubMed]
A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa